Seres Therapeutics to Host Webcast on July 8, 2026, to Discuss Results of Investigator-Sponsored Trial of Seres’ SER-155 in Immune Checkpoint Inhibitor-Related Enterocolitis
Go back to Seres Therapeutics to Host Webcast on July 8, 2026, to Discuss Results of Investigator-Sponsored Trial of Seres’ SER-155 in Immune Checkpoint Inhibitor-Related Enterocolitis| (NASDAQ: MCRB) | Delayed: 5.23 -0.05 (0.95%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.28 | 52 Week High | $44.51 | |||
| Open | $5.21 | 52 Week Low | $8.05 | |||
| Day High | $5.36 | P/E | N/A | |||
| Day Low | $5.11 | EPS | $0.00 | |||
| Volume | 29,817 | |||||

